Literature DB >> 24166313

Lentiviral overexpression of miRNAs.

Hannah Zöllner1, Stephan A Hahn, Abdelouahid Maghnouj.   

Abstract

Deregulation of microRNAs (miRNAs) has been attributed to almost any human disease analyzed to date. This calls for models and experimental strategies for functional analyses of miRNAs enabling miRNA overexpression or suppression in target cell and/or tissues. Lentiviral vector (LV)-based technologies allow the long-term overexpression of miRNAs in nearly all cell types in an easy and rapid manner and are therefore popular tools for this application. In this chapter we describe the cloning of LV miRNA expression vectors as well as the production of virus particles for target cell infection and stable expression of miRNAs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24166313     DOI: 10.1007/978-1-62703-703-7_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  MiR-29a-Mediated CD133 Expression Contributes to Cisplatin Resistance in CD133+ Glioblastoma Stem Cells.

Authors:  Liang Yang; Nan Li; Zhongjie Yan; Chen Li; Zongmao Zhao
Journal:  J Mol Neurosci       Date:  2018-09-29       Impact factor: 3.444

2.  Hypoxic Environment Promotes Barrier Formation in Human Intestinal Epithelial Cells through Regulation of MicroRNA 320a Expression.

Authors:  Megan L Stanifer; Steeve Boulant; Stephanie Muenchau; Rosalie Deutsch; Ines J de Castro; Thomas Hielscher; Nora Heber; Beate Niesler; Marina Lusic
Journal:  Mol Cell Biol       Date:  2019-06-27       Impact factor: 4.272

Review 3.  MicroRNA.

Authors:  Thomas X Lu; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2017-10-23       Impact factor: 10.793

4.  miR-140-5p Attenuates Hypoxia-Induced Breast Cancer Progression by Targeting Nrf2/HO-1 Axis in a Keap1-Independent Mechanism.

Authors:  Megharani Mahajan; Sandhya Sitasawad
Journal:  Cells       Date:  2021-12-22       Impact factor: 6.600

5.  Engineering Novel Lentiviral Vectors for Labelling Tumour Cells and Oncogenic Proteins.

Authors:  Seçkin Akgül; Carolin Offenhäuser; Anja Kordowski; Bryan W Day
Journal:  Bioengineering (Basel)       Date:  2022-02-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.